Trial Profile
A Phase II Study of Adjuvant Chemotherapy of S-1 With Oxaliplatin in Gastric Cancer at Stage IIIB/ IV (AJCC 6th) After D2 Resection
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 Dec 2022
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms SOHUG
- 25 Mar 2020 Status changed from recruiting to discontinued.
- 14 Mar 2018 Planned End Date changed from 1 Feb 2019 to 1 Feb 2020.
- 14 Mar 2018 Planned primary completion date changed from 1 Feb 2019 to 1 Feb 2020.